Preventing mother-to-child transmission of HIV in developing countries: Recent developments and ethnical implications

References

• UNAIDS Joint United Nations Programme on HIV/AIDS. AIDS epidemic update: December 199.
   Google Scholar
• World Health Organisation. Recommendations on the safe and effective use of short-course ZDV for prevention of motherto-child transmission of HIV. Weekly Epidemiological Record. 41: 1998; 313–320. Genev.
   Google Scholar
• M. Cartoux, N. Meda, P Van de Perre. Ghent International Working Group on Mother-to-Child Transmission of HI. Acceptability of voluntary HIV testing by pregnant women in developing countries: an international survey. AIDS. 12: 1998; 2489–2493.
   PubMed Web of Science ®Google Scholar
• E.M. Connor, R.S. Sperling, R. Gelber. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine. 331: 1994; 1173–1180.
   PubMed Web of Science ®Google Scholar
• S.Z. Wiktor, E. Ekpini, J.M. Karon. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte D’Ivoire: a randomised trial. Lancet. 353: 1999; 781–785.
   PubMed Web of Science ®Google Scholar
• F. Dabis, P. Msellati, N. Meda. DITRAME Study Grou. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d’Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet. 353: 1999; 786–792.
   PubMed Web of Science ®Google Scholar
• DITRAME ANRS 049 Study Group. 15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. Lancet. 353: 1999; 2050–2051.
   Google Scholar
• N. Shaffer, R. Chuachoowong, P. Mock. Bangkok Collaborative Perinatal HIV Transmission Study Grou. Lancet. 353: 1999; 773–780.
   Google Scholar
• L.A. Guay, P. Musoke, T. Fleming. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 354: 1999; 795–802.
   PubMed Web of Science ®Google Scholar
• L.M. Mofenson. Short-course zidovudine for prevention of perinatal infection. Lancet. 354: 1999; 766–767.
   Web of Science ®Google Scholar
• H.A. Aka-Dago-Akribi, A. Desgrées du Loû, P. Msellati. Issues surrounding reproductive choices for women living with HIV in Abidjan, Côte d’Ivoire. Reproductive Health Matters. 7: 1999; 20–29.
   Google Scholar
• Canadian HIV/AIDS Legal Network. Rapid HIV Screening at the Point of Care: Legal and Ethical Questions. 2000. Montreal, Canad. www.aidslaw.ca
   Google Scholar
• E. Marseille, J.G. Kahn, F. Mmiro. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 354: 1999; 803–809.
   PubMed Web of Science ®Google Scholar
• P. Musoke, L.A. Guay, D. Bagenda. A phase I/II study of the safety and pharmacokinetics of neviparine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS. 13(4): 1999; 479–486.
   Web of Science ®Google Scholar
• D.V. Havlir, S. Eastman, A. Gamst, D. Richman. Nevirapineresistant human immunodeficiency virus kinetics of replication and estimated prevalence in untreated patients. Journal of Virology. 70: 1996; 7894–7899.
   PubMed Web of Science ®Google Scholar
• G. Becker-Pergola, L. Guay, F. Mmiro Selection of the K103N nevirapine resistance mutation in Ugandan women receiving NVP prophylaxis to prevent HIV-1 Vertical transmision (HIVNET-006) 7th Conference on Retroviruses and Opportunistic Infections. San Francisco, 30 Jan–2 Feb 2000,
   Google Scholar
• World Health Organization. Use of nevirapine to reduce motherto-child transmission of HIV (MCTCT). WHO Review of Reported Drug Resistance. 24 March 2000. Geneva. www.who.int/reproductivehealth/publications/ nevirapine/report.htm
   Google Scholar
• M.S. Hirsch, B. Conway, R.T. D’Aquila. International AIDS Society-USA Pane. Antiretroviral drug resistance testing in adults with HIV infection. Implications for clinical management. JAMA. 279: 1998; 1984–1991.
   PubMed Web of Science ®Google Scholar
• R.E. Giles, K.R. Perry, J.V. Parry. Simple/rapid test devices for anti-HIV screening: do they come up to the mark?. Journal of Medical Virology. 59: 1999; 104–109.
   PubMed Web of Science ®Google Scholar
• R.G. Downing, R.A. Otten, E. Marum. Optimizing the delivery of HIV counselling and testing services: the Uganda experience using rapid HIVA antibody test algorithms. Journal of Acquired Immune Deficiency Syndrome & Human Retrovirol. 18: 1998; 384–388.
   PubMedGoogle Scholar
• BBC News Online. January 2000. http://news,bbc.co.uk/hi/ english/world
   Google Scholar
• Gannon JC. The global infectious disease threat and its implications for the USA. www.cia.gov/cia/publications/ nie/report/nie99-17d.html
   Google Scholar
• M. Berer. Reducing perinatal HIV transmission in developing countries in the context of antenatal and delivery care and breastfeeding: Supporting infant survival by supporting women’s survival. Bulletin of WHO. 77(11): 1999; 871–877.
   Web of Science ®Google Scholar